Momenta Pharmaceuticals Inc. (MNTA) Jumps 8.23% on February 16

Equities Staff |

Momenta Pharmaceuticals Inc. (MNTA) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 8.23% to $11.31, representing a gain of $0.86 per share. Some 368,152 shares traded hands on 3,511 trades, compared with an average daily volume of 758,227 shares out of a total float of 69 million. The stock opened at $10.51 and traded with an intraday range of $11.32 to $10.48.

After today's gains, Momenta Pharmaceuticals Inc. reached a market cap of $780.36 million. Momenta Pharmaceuticals Inc. has had a trading range between $25.56 and $9.91 over the last year, and it had a 50-day SMA of $14.08 and a 200-day SMA of $18.28.

Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease.

Momenta Pharmaceuticals Inc. is based out of Cambridge, MA and has some 256 employees. Its CEO is Craig A. Wheeler.

For a complete fundamental analysis analysis of Momenta Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for MNTA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Taranis Resources Inc.

Taranis Resources Inc is an exploration stage company. The Company along with its subsidiaries is engaged in the acquisition and exploration of mineral properties. Its projects include Thor Property in…

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…